ESPR — Esperion Therapeutics, Inc. stock price, charts and financials

QT84Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc. (NASDAQ: ESPR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
3.18
-0.01-0.31%
OverviewShort InterestFilings
ESPRQT84Esperion Therapeutics, Inc.·NASDAQ
3.18-0.31%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 23, 202615-12G15-12G
Jul 15, 2026EFFECTNotice of effectiveness
Jul 15, 2026EFFECTNotice of effectiveness
Jul 15, 2026EFFECTNotice of effectiveness
Jul 15, 2026EFFECTNotice of effectiveness
Jul 15, 2026EFFECTNotice of effectiveness
Jul 15, 2026EFFECTNotice of effectiveness
Jul 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 13, 2026S-8 POSS-8 POS
Jul 13, 20268-KCurrent report
Jul 13, 2026S-8 POSS-8 POS
Jul 13, 2026S-8 POSS-8 POS
Jul 13, 2026S-8 POSS-8 POS
Jul 13, 2026S-8 POSS-8 POS
Jul 13, 2026S-8 POSS-8 POS
Jul 13, 2026S-8 POSS-8 POS
Jul 13, 2026POS AMPost-effective amendment
Jul 13, 2026POS AMPost-effective amendment
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 2026POS462BPOS462B
Jul 13, 2026S-8 POSS-8 POS
Jul 13, 2026S-8 POSS-8 POS
#1 / 25 of 451
Page
▼
/ 19